Vimarsana
Biggest News Aggregation in the World

Page 6 - Nexalin Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nexalin Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nexalin Technology Today - Breaking & Trending Today

Nexalin Technology Establishing Advisory Board to Help Commercialize Neurostimulation Products for Military, Government Customers - Vimarsana News

Nexalin Technology Establishing Advisory Board to Help Commercialize Neurostimulation Products for Military, Government Customers

Nexalin Technology, a developer of neurostimulation products, is establishing a military and government advisory board, whose purpose is to help formulate and implement a strategy for the commercialization of the company's deep-brain stimulation devices. The advisory board will be led by David Lasseter, the founder of Horizons Global Solutions, a provider of consulting services with a focus on biotechnology, intelligence, law enforcement and national security, Nexalin said Wednesday.

Civilian | ExecutiveBiz - Vimarsana News

Civilian | ExecutiveBiz

Looking for the latest GovCon news about Civilian? Click here to get our daily Government Contracting News updates.

Nexalin Technology (NASDAQ:NXL) Shares Down 2.1% - Vimarsana News

Nexalin Technology (NASDAQ:NXL) Shares Down 2.1%

Nexalin Technology, Inc. (NASDAQ:NXL – Get Free Report)’s stock price fell 2.1% on Tuesday . The stock traded as low as $0.28 and last traded at $0.29. 3,991 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 40,465 shares. The stock had previously closed at $0.29. Nexalin Technology […]

Reviewing Nexalin Technology (NASDAQ:NXL) and Guided Therapeutics (OTCMKTS:GTHP) - Vimarsana News

Reviewing Nexalin Technology (NASDAQ:NXL) and Guided Therapeutics (OTCMKTS:GTHP)

Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations. Institutional & Insider Ownership 0.2% of Nexalin […]

Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin's Neurostimulation Device to Penetrate Deep Brain Structures -October 16, 2023 at 08:31 am EDT - Vimarsana News

Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin's Neurostimulation Device to Penetrate Deep Brain Structures -October 16, 2023 at 08:31 am EDT

Study reveals that Nexalin’s non-invasive, deep frequency stimulation medical device can directly stimulate the deep intracranial nuclei, an area of the brain frequently associated with trauma and...